QUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop f

EQS-News: QUANTRO Therapeutics GmbH / Key word(s): MiscellaneousQUANTRO Therapeutics reaches a milestone in the collaboration with Boehringer Ingelheim to develop first-in-class cancer treatments 04.06.2024 / 23:07 CET/CESTThe issuer is solely responsible for the content of this announcement.QUANTRO Therapeutics rea...

Related Keywords

Austria ,Vienna ,Wien ,Johanna Kobler ,Katja Arnold ,Norbert Kraut ,Shaun Brown ,Michael Bauer ,Distribution Services ,Boehringer Ingelheim Venture Fund ,Boehringer Ingelheim ,Mc Services ,Transcriptional Fingerprint ,Global Head ,Cancer Research ,Drug Discovery ,Corporate News ,Regulatory Announcements ,